Effect of l -carnitine supplementation on renal anemia in patients on hemodialysis: a meta-analysis

ConclusionThe present meta-analysis indicated thatl-carnitine therapy significantly increased plasmal-carnitine concentrations, improved the response to ESA, decreased the required ESA doses in patients receiving hemodialysis, and maintained hemoglobin and hematocrit levels.l-carnitine supplementation should be supported in hemodialysis patients. However, the relationship betweenl-carnitine treatment and long-term outcomes is still unclear. Further high-quality RCTs are needed to verify our findings.
Source: International Urology and Nephrology - Category: Urology & Nephrology Source Type: research